drugset / Trial / NCT06914193
Esketamine Combined With PRF of DRG for Postherpetic Neuralgia
Not yet recruiting
186 enrolled
Beijing Tiantan Hospital
Beijing Ditan Hospital · collabBeijing Xiaotangshan Hospital · collabHengshui People's Hospital · collabThe First Hospital of Fangshan District,Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) of dorsal root ganglion(DRG) against that of PRF monotherapy in patients with postherpetic neuralgia(PHN).
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-07-01
- Completion
- 2026-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | — | Intravenous |
| Background | Pregabalin | Small molecule | — | — |